Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer.

MLA

Shahin, Sophia A., et al. “Hyaluronic Acid Conjugated Nanoparticle Delivery of SiRNA against TWIST Reduces Tumor Burden and Enhances Sensitivity to Cisplatin in Ovarian Cancer.” Nanomedicine : Nanotechnology, Biology, and Medicine, vol. 14, no. 4, June 2018, pp. 1381–94. EBSCOhost, https://doi.org/10.1016/j.nano.2018.04.008.

APA

Shahin, S. A., Wang, R., Simargi, S. I., Contreras, A., Parra Echavarria, L., Qu, L., Wen, W., Dellinger, T., Unternaehrer, J., Tamanoi, F., Zink, J. I., & Glackin, C. A. (2018). Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer. Nanomedicine : Nanotechnology, Biology, and Medicine, 14(4), 1381–1394. https://doi.org/10.1016/j.nano.2018.04.008

Chicago

Shahin, Sophia A, Ruining Wang, Shirleen I Simargi, Altagracia Contreras, Liliana Parra Echavarria, Louise Qu, Wei Wen, et al. 2018. “Hyaluronic Acid Conjugated Nanoparticle Delivery of SiRNA against TWIST Reduces Tumor Burden and Enhances Sensitivity to Cisplatin in Ovarian Cancer.” Nanomedicine : Nanotechnology, Biology, and Medicine 14 (4): 1381–94. doi:10.1016/j.nano.2018.04.008.